Evidence map›Paper›PMID 40572493›Full record

ArticleMolecules (Basel, Switzerland)2025

In Vitro Effect of Ferruginol, Tanshinone, and Carnosol Analogues on the Proliferation of Three Breast Cancer Cell Lines.

Miguel A González-Cardenete, William E Mendoza-Hernández, Sydney L Lawson, Fatima Rivas

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Miguel A González-CardeneteInstituto de Tecnología Química, Universitat Politècnica de València-Consejo Superior de Investigaciones Científicas, Avda. de los Naranjos s/n, 46022 Valencia, Spain.ORCID 0000-0002-8762-0426
William E Mendoza-HernándezInstituto de Tecnología Química, Universitat Politècnica de València-Consejo Superior de Investigaciones Científicas, Avda. de los Naranjos s/n, 46022 Valencia, Spain.ORCID 0009-0009-3663-8552
Sydney L LawsonDepartment of Chemistry, Louisiana State University, 133 Choppin Hall, Baton Rouge, LA 70803, USA.ORCID 0009-0001-2353-318X
Fatima RivasDepartment of Chemistry, Louisiana State University, 133 Choppin Hall, Baton Rouge, LA 70803, USA.ORCID 0000-0003-3643-2035

Funding

Elucidating the mode of action of the abietanes to develop potential therapeutic agents_supplementR15GM148983 · NIGMS · LOUISIANA STATE UNIV A&M COL BATON ROUGE · PI RIVAS, FATIMA R · 2022 to 2023
$467k
Generalitat Valenciana CIAICO/2022/220Louisiana Board of Regents Support Fund LEQSF-RD-A-05Ministerio de Ciencia, Spain CEX2021-001230-SNIGMS NIH HHS R15 GM148983
6 · The paper itself

Abstract

Ferruginol, tanshinones and carnosol are considered privileged natural products due to their demonstrated diverse biological activities with relevance to cancer research. Globally, cancer continues to be a major contributor to mortality rates, making these compounds potentially valuable molecular scaffolds for further development as potential anticancer agents. In this work, a focused library of ferruginol, tanshinone IIA, and carnosol analogues was studied to examine their effectiveness against various solid tumor models. The compounds were efficiently synthesized from either methyl 12-hydroxy-dehydroabietate or 12-hydroxydehydroabietylamine in 1-3 step processes with good chemical yields. The compounds that were synthesized underwent a methodical evaluation using multiple biological tests (including viability assays, clonogenic assays, and mitochondrial membrane polarization measurements) to determine their ability to inhibit in vitro the growth of three breast cancer cell linages. It was determined that while most compounds exhibited biological activity, compounds

Indexed as

AbietanesBreast NeoplasmsAntineoplastic Agents, PhytogenicCell Line, TumorCell ProliferationCell SurvivalFemaleHumansAbietanesAntineoplastic Agents, Phytogeniccarnosolferruginoltanshinoneabietanebreast cancer cellscarnosolcytotoxicityferruginoltanshinone

Identifiers

PMID40572493
PMCPMC12195677

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.